Investment Strategies for Solid, Doosan Enerbility, and More?

Solid, expected to show improved performance, benefits from a strategy of long-term holding with proportion adjustment. Given the potential for benefiting from infrastructure investments due to U.S. regulations on Chinese communication equipment, a proportion exceeding 20% is burdensome, but it's advisable to observe trends until the first half of next year and adjust the proportion at the breakeven point.

Kwak Yu-jeong, CEO of JW Investment, pointed out that even for stocks with strong fundamentals, a proportion over 20% is risky. She suggested a strategy of adjusting the proportion at the breakeven point while monitoring stock trends until the first half of next year.

Doosan Enerbility's stock momentum was weak despite the positive news of supplying AI gas turbines to SpaceX, attributed to the long lead times for power facilities.

According to a Morgan Stanley report, AI power shortages cause a waiting period of over two years for power facilities, and even longer for nuclear power, thus relatively marginalizing the latter.

A current proportion of 39% is recommended to be held without additional purchases or intervention. A strategy of reducing 10% of the proportion upon reaching the target price of 130,000 won and holding the remaining quantity long-term was suggested.

Hy-Gen R&M incurred significant losses before and after being designated as an investment alert stock. Following a disclosure of poor accounting practices, other negative factors like war exacerbated a sharp decline in stock price.

Advice is needed on appropriate additional purchase price levels and strategies to recover from losses.

He analyzed that buying on tomorrow's adjustment would be advantageous, while it's better to wait if there's a sudden surge.

He suggested a strategy of selling all holdings upon reaching the average price, or selling half and holding the remaining 10% to realize profits.

As financial risks are not yet fully resolved, a strategy focused on minimizing losses and exiting is recommended at this time.

The purchase price is 1,623,000 won, and it has recently entered a slight profit zone.

Despite news of an MLCC supply contract, there's significant concern about missing the selling timing due to the high proportion.

This is mainly attributed to increased sales of automotive MLCCs due to rising demand for autonomous vehicles.

Along with a 6 trillion won investment in substrates, the company possesses new growth engines such as glass substrates and humanoid camera modules, promising a long-term growth story.

A strategy of selling in portions according to trend movements is necessary.

At a time when rapid sector rotation is observed across the market, risk management through proportion adjustment is crucial.

A strategy of selling in portions while riding the trend is needed to maximize profits and diversify the portfolio.

For Samchun dang Pharm, stabilization at the 260,000 won level is key to its future stock performance. Regardless of interest rate hikes, the news of a macular degeneration treatment contract acts as an upward driver, showing a profit game characteristic of individual stocks.

Team Leader Min Pureum predicted that successful stabilization at the 260,000 won level would be a critical variable determining future stock movement.

CEO Kwak Yu-jeong judged the current moment as the beginning of a new investment cycle for L&F.

The rise in L&F's stock price is driven by increased demand in the North American ESS market and changes in the global supply chain. With SK and Samsung SDI's North American production bases slated for mass production, the likelihood of domestic companies like L&F and POSCO Future M supplying LFP cathodes instead of Chinese products is growing.

The expectation of turning profitable from the second half of this year with LFP cathode mass production is also a positive factor.

She recommended a strategy of holding until the first half of next year rather than short-term trading.

To maximize profits, she suggested a strategy of liquidating 10% of the proportion around 150,000 won and holding the remaining quantity until next year.

Recent issues of personal information leaks in the financial sector and strong performance by U.S. security companies have positively impacted the domestic security stock market.

CEO Kwak Yu-jeong questioned the continuity of security-related stocks that closed with a bearish candle after a gap-up opening.

Given the strong short-term profit-taking sentiment, for XG-Gate, she recommended a conservative strategy of reducing 50% of the proportion and dealing with the remaining quantity during the week.

She judged this to be more advantageous for managing risk amid uncertain supply and demand conditions.

Team Leader Min Pureum classified nuclear power stocks into main equipment suppliers like Doosan Enerbility and constructors like Hyundai E&C and Daewoo E&C. Unlike Hyundai E&C, already recognized as a global company, Daewoo E&C has entered a re-valuation phase thanks to the Czech nuclear power project.

Despite a general adjustment period for nuclear power stocks, the target price for Daewoo E&C was set at over 25,000 won, up to 30,000 won.

Considering the stock's characteristic of a 40% current proportion, a strategy of selling half the proportion if it falls below 17,000 won and repurchasing on rebound was recommended.

Kia continues its downward trend, breaking its previous low, and Team Leader Min Pureum mentioned the possibility of it falling to the 100,000 won mark with further decline. The high-interest environment, increasing the burden of installment interest, negatively impacts automotive demand and consequently the stock price.

With the likelihood of interest rate hikes continuing into next year, a significant amount of time is expected before Kia's stock price rebounds.

As the holding proportion is relatively small at 10%, Team Leader Min Pureum suggested that confirming losses and engaging in replacement trading for other growth-oriented stocks like robot stocks would be a more efficient strategy.